Differential effects of escitalopram challenge on disgust processing in obsessive-compulsive disorder

Behavioural Brain Research

Volumn 226, Issue 1, 2012, Pages 274-280

  Lochner, Christine ^a   Simmons, Candice ^a   Kidd, Martin ^a   Chamberlain, Samuel R ^b   Fineberg, Naomi A ^b   van Honk, Jack ^c,d   Ipser, Jonathan ^d   Stein, Dan J ^a,d  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Disgust recognition; Escitalopram; Obsessive compulsive disorder; Pharmacological challenge

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; EMOTIONALITY; FACIAL EXPRESSION; FEMALE; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; PATTERN RECOGNITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SINGLE DRUG DOSE; SYMPTOMATOLOGY;

ADULT; CITALOPRAM; DOUBLE-BLIND METHOD; EMOTIONS; FACIAL EXPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; RECOGNITION (PSYCHOLOGY); SEROTONIN UPTAKE INHIBITORS;

EID: 80053649022     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.09.029     Document Type: Article

References (50)

1. Corcoran K.M., Woody S.R., Tolin D.F. Recognition of facial expressions in obsessive-compulsive disorder. J Anxiety Disord 2008, 22:56-66.
2. Persad M., Polivy J. Differences between depressed and non-depressed individuals in the recognition of and response to facial emotional cues. J Abnorm Psychol 1993, 102:358-368.
3. Douglas K.M., Porter R.J. Recognition of disgusted facial expressions in severe depression. Br J Psychiatry 2010, 197:156-157.
4. Sprengelmeyer R., Steele J.D., Mwangi B., Kumar P., Christmas D., Milders M., et al. The insular cortex and the neuroanatomy of major depression. J Affect Disord 2011, 133:120-127.
5. Lewis S.F., Garver D.L. Treatment and diagnostic subtype in facial affect recognition in schizophrenia. J Psychiatr Res 1995, 29:5-11.
6. Leung J.S., Lee T.M., Lee C.C. Facial emotion recognition in Chinese with schizophrenia at early and chronic stages of illness. Psychiatry Res 2011, Aug 17. [Epub ahead of print].
7. Edwards J., Pattison P.E., Jackson H.J., Wales R.J. Facial affect and affective prosody recognition in first-episode schizophrenia. Schizophr Res 2001, 48:235-253.
8. Kohler C.G., Turner T.H., Bilker W.B., Brensinger C.M., Siegel S.J., Kanes S.J., et al. Facial emotion recognition in schizophrenia: intensity effects and error pattern. Am J Psychiatry 2003, 160:1768-1774.
9. Phillips M.L., Mataix-Cols D. Patterns of neural response to emotive stimuli distinguish the different symptom dimensions of obsessive-compulsive disorder. CNS Spectr 2004, 9:275-283.
10. Stein D.J., Liu Y., Shapira N.A., Goodman W.K. The psychobiology of obsessive-compulsive disorder: how important is the role of disgust?. Curr Psychiatry Rep 2001, 3:281-287.
11. Sprengelmeyer R., Young A.W., Pundt I., Sprengelmeyer A., Calder A.J., Berrios G., et al. Disgust implicated in obsessive-compulsive disorder. Proc R Soc Lond B: Biol Sci 1997, 264:1767-1773.
12. Grisham J.R., Henry J.D., Williams A.D., Bailey P.E. Socioemotional deficits associated with obsessive-compulsive symptomatology. Psychiatry Res 2010, 175:256-259.
13. David B., Olatunji B.O., Armstrong T., Ciesielski B.G., Bondy C.L., Broman-Fulks J. Incremental specificity of disgust sensitivity in the prediction of obsessive-compulsive disorder symptoms: cross-sectional and prospective approaches. J Behav Ther Exp Psychiatry 2009, 40:533-543.
14. Tolin D.F., Woods C.M., Abramowitz J.S. Disgust sensitivity and obsessive-compulsive symptoms in a non-clinical sample. J Behav Ther Exp Psychiatry 2006, 37:30-40.
15. Power M., Dalgleish T. Cognition and emotion: from order to disorder 1997, Psychology Press, East Sussex, UK.
16. Woody S.R., Tolin D.F. The relationship between disgust sensitivity and avoidant behavior: studies of clinical and nonclinical samples. J Anxiety Disord 2002, 16:543-559.
17. Woody S.R., Teachman B.A. Intersection of disgust and fear: normal and pathological views. Clin Psychol: Sci Pract 2000, 7:291-311.
18. Buhlmann U., McNally R.J., Etcoff N.L., Tuschen-Caffier B., Wilhelm S. Emotion recognition deficits in body dysmorphic disorder. J Psychiatr Res 2004, 38:201-206.
19. Parker H.A., McNally R.J., Nakayama K., Wilhelm S. No disgust recognition deficit in obsessive-compulsive disorder. J Behav Ther Exp Psychiatry 2004, 35:183-192.
20. Delorme R., Betancur C., Callebert J., Chabane N., Laplanche J.L., Mouren-Simeoni M.C., et al. Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder. Neuropsychopharmacology 2005, 30:1539-1547.
21. Wendland J.R., Moya P.R., Kruse M.R., Ren-Patterson R.F., Jensen C.L., Timpano K.R., et al. A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder. Hum Mol Genet 2008, 17:717-723.
22. Eddy K.T., Dutra L., Bradley R., Westen D. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. Clin Psychol Rev 2004, 24:1011-1030.
23. Stein D.J., Spadaccini E., Hollander E. Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. Int Clin Psychopharmacol 1995, 10:11-18.
24. Fineberg N.A., Gale T.M. Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol 2005, 8:107-129.
25. Harmer C.J., Bhagwagar Z., Perrett D.I., Vollm B.A., Cowen P.J., Goodwin G.M. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 2003, 28:148-152.
26. Chamberlain S.R., Muller U., Blackwell A.D., Clark L., Robbins T.W., Sahakian B.J. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 2006, 311:861-863.
27. Waugh J., Goa K.L. Escitalopram: a review of its use in the management of major depressive and anxiety disorders. CNS Drugs 2003, 17:343-362.
28. Rao N. The clinical pharmacokinetics of escitalopram. Clin Pharmacokinet 2007, 46:281-290.
29. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl. 20):22-33.
30. du Toit P.L., van Kradenburg J., Niehaus D., Stein D.J. Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview. Compr Psychiatry 2001, 42:291-300.
31. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989, 46:1006-1011.
32. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Delgado P., Heninger G.R., et al. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry 1989, 46:1012-1016.
33. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
34. Davidson J., Turnbull C.D., Strickland R., Miller R., Graves K. The Montgomery-Asberg Depression Scale: reliability and validity. Acta Psychiatr Scand 1986, 73:544-548.
35. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959, 32:50-55.
36. Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI) 1999, Harcourt Assessment, San Antonio, TX.
37. Hays J.R., Reas D.L., Shaw J.B. Concurrent validity of the Wechsler abbreviated scale of intelligence and the Kaufman brief intelligence test among psychiatric inpatients. Psychol Rep 2002, 90:355-359.
38. Alves-Neto W.C., Guapo V.G., Graeff F.G., Deakin J.F., Del Ben C.M. Effect of escitalopram on the processing of emotional faces. Braz J Med Biol Res 2010, 43:285-289.
39. Montagne B., Kessels R.P., De Haan E.H., Perrett D.I. The Emotion Recognition Task: a paradigm to measure the perception of facial emotional expressions at different intensities. Percept Mot Skills 2007, 104:589-598.
40. Lundqvist D., Flykt A., Ohman A. The Karolinska directed emotional faces 1998, Psychology Section, Department of Clinical Neuroscience Karolinska Institute Stockholm.
41. Ekman P., Friesen W.L. Pictures of facial affect 1976, Consulting Psychologist Press.
42. Crino R.D., Andrews G. Obsessive-compulsive disorder and axis I-comorbidity. J Anxiety Disord 1996, 10:37-46.
43. Tukel R., Polat A., Ozdemir O., Aksut D., Turksoy N. Comorbid conditions in obsessive-compulsive disorder. Compr Psychiatry 2002, 43:204-209.
44. Browning M., Reid C., Cowen P.J., Goodwin G.M., Harmer C.J. A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacol 2007, 21:684-690.
45. Del-Ben C.M., Deakin J.F., McKie S., Delvai N.A., Williams S.R., Elliott R., et al. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology 2005, 30:1724-1734.
46. Anderson I.M., Del-Ben C.M., McKie S., Richardson P., Williams S.R., Elliott R., et al. Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study. Neuroreport 2007, 18:1351-1355.
47. Bigos K.L., Pollock B.G., Aizenstein H.J., Fisher P.M., Bies R.R., Hariri A.R. Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology 2008, 33:3221-3225.
48. Murphy S.E., Norbury R., O'Sullivan U., Cowen P.J., Harmer C.J. Effect of a single dose of citalopram on amygdala response to emotional faces. Br J Psychiatry 2009, 194:535-540.
49. Graeff F.G., Zangrossi H. The dual role of serotonin in defense and the mode of action of antidepressants on generalized anxiety and panic disorders. Cent Nerv Syst Agents Med Chem 2010, 10:207-217.
50. Berle D., Phillips E.S. Disgust and obsessive-compulsive disorder: an update. Psychiatry 2006, 69:228-238.